Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02051218
Brief Title: Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks

First Submitted : January 29, 2014
First Submitted that Met QC Criteria : January 29, 2014
First Posted : January 31, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : June 8, 2021
Last Update Posted : June 9, 2021